GuiZhou SanLi Pharmaceutical Co.,Ltd

Shanghai Stock Exchange 603439.SS

GuiZhou SanLi Pharmaceutical Co.,Ltd Free Cash Flow Yield on January 27, 2025: 3.27%

GuiZhou SanLi Pharmaceutical Co.,Ltd Free Cash Flow Yield is 3.27% on January 27, 2025, a 32.01% change year over year. Free cash flow yield compares the return from free cash flow to the market cap; higher yield suggests attractive investment.
  • GuiZhou SanLi Pharmaceutical Co.,Ltd 52-week high Free Cash Flow Yield is 3.79% on August 23, 2024, which is 15.89% above the current Free Cash Flow Yield.
  • GuiZhou SanLi Pharmaceutical Co.,Ltd 52-week low Free Cash Flow Yield is 2.34% on March 18, 2024, which is -28.29% below the current Free Cash Flow Yield.
  • GuiZhou SanLi Pharmaceutical Co.,Ltd average Free Cash Flow Yield for the last 52 weeks is 3.02%.
Key data
Date Free Cash Flow Yield Market Value Added (MVA) Price to Book Ratio (P/B) Price to Earnings Ratio (P/E)
Market news
Loading...
SV Wall Street
Shanghai Stock Exchange: 603439.SS

GuiZhou SanLi Pharmaceutical Co.,Ltd

CEO Mr. Hai Zhang
IPO Date April 28, 2020
Location China
Headquarters Xiayun Industrial Park
Employees 2,282
Sector Health Care
Industries
Description

GuiZhou SanLi Pharmaceutical Co.,LTD. engages in the research and development, production, and marketing of pharmaceutical products. It offers pediatric medication, respiratory system medication, cardiovascular and cerebrovascular drugs, digestive medicine, trauma injury medication, rehabilitation medicine, and ophthalmic medicine. The company was founded in 1995 and is based in Guiyang, China.

Similar companies

603590.SS

Beijing Konruns Pharmaceutical Co.,Ltd.

USD 3.31

NA

600645.SS

Vcanbio Cell & Gene Engineering Corp., Ltd

USD 2.72

NA

603229.SS

Zhejiang Ausun Pharmaceutical Co., Ltd.

USD 1.17

NA

603566.SS

Pulike Biological Engineering, Inc.

USD 1.70

NA

603896.SS

Zhejiang Shouxiangu Pharmaceutical Co., Ltd.

USD 2.76

NA

StockViz Staff

February 1, 2025

Any question? Send us an email